COGNANO is the only startup that has the first big-data in history for antigen -labeled antibody sequences. We have succeeded in uncovering unknown drug discovery targets from antibody information. Target molecule selection which determines the success rate of drug discovery by our own IT algorithm.
Area of Interest
North America
Europe
Site-visit
Not allowed
SDGs we are working on
9.Industry, innovation, infrastructure3.Good health and well-being
Registered Keyword
ADC, TCB, and CAR-T drug discovery targeting new biomarkers discovered by big data engineering ~Providing a Bio-IT platform for therapeutics against 7 UNMET cancers~